Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer
Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today […]
Inspire Biotherapeutics Launches with Pre-seed Investment to Target Monogenic and Acquired Lung Diseases with Proprietary AAVenger Gene Therapy Platform
Inspire Biotherapeutics, an emerging biotech company with a mission to create life-saving gene therapies for […]
Leucid Bio and Great Ormond Street Hospital Enter Commercial Agreement at New Gene Therapy Manufacturing Centre
Leucid Bio, a biotech company pursuing a differentiated approach to develop next-generation Chimeric Antigen Receptor […]
Catamaran Bio Selects OmniaBio as Partner to Develop and Manufacture Allogeneic CAR-NK Cell Therapies
Catamaran Bio, a biotechnology company developing off-the-shelf NK cell therapies to treat cancer, and OmniaBio, […]
Gene Therapy Candidate for Amyotrophic Lateral Sclerosis (ALS) Demonstrates Bioactivities in a Murine Model of the Disease
Anew Medical, a medical product development company, announced results presented at the European Society of […]
Genezen Announces the Appointment of Steven J. Favaloro as Chief Executive Officer to Support Next Phase of Growth
Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in lentiviral […]
Cell One Partners and Center for Breakthrough Medicines Announce Strategic Partnership to Accelerate Cell and Gene Therapy Commercialization
Cell One Partners, an industry-leading strategic consulting firm positioned to support cell and gene therapy […]
BioMarin Provides Update on FDA Review of ROCTAVIAN™ (Valoctocogene Roxaparvovec) Gene Therapy for Adults with Severe Hemophilia A
BioMarin Pharmaceutical, a global biotechnology company dedicated to transforming lives through genetic discovery, today announced […]
Illumina and Myriad Genetics Expand Partnership to Broaden Access to HRD Testing in the United States
Illumina, a global leader in DNA sequencing and array-based technologies, and Myriad Genetics, a leader […]
Poseida Therapeutics Appoints Five New Members to Its Gene Therapy Scientific Advisory Board
Poseida Therapeutics, a clinical-stage cell and gene therapy company advancing a new class of treatments […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more